E. Ganofszky

Inflammatory Breast Cancer—Comparing the Effectivity of Preoperative Docetaxel-Epirubicine Protocol to Conventional Antracycline-Containing Chemotherapy to Achieve Clinical Benefit and Complete Pathological Response

L. Urban, E. Hitre, I. Láng, 2011, Pathology & Oncology Research.

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study.

Z. Szentirmay, E. Hitre, I. Láng, 2013, European journal of cancer.

A comparative analysis on the efficacy and safety of intaxel® and taxol® in advanced metastatic breast cancer.

E. Hitre, I. Láng, Z. Horváth, 2013, Journal of clinical and diagnostic research : JCDR.

Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer

E. Hitre, T. Pintér, I. Láng, 2018, Pathology & Oncology Research.

Biomarkers Derived From Routine Blood Cell Counts Differentially Predict Disease-Free and Overall Survival After Neoadjuvant Treatment of Triple-Negative Breast Cancer

T. Pintér, B. Madaras, B. Budai, 2021 .

[Changes in renal function during bisphosphonate treatment of breast cancer patients].

E. Hitre, I. Láng, Z. Horváth, 2008, Magyar Onkológia.